Although the underlying mechanisms of the cognition-enhancing effect remain elusive, PDE4D inhibition appears to be an interesting novel therapeutic option for cognitive deficits, particularly in AD [59,60]. The gene discussed is PDE4D; the disease is Cognitive impairment.